PURIXAN

Peak

mercaptopurine

NDAORALSUSPENSION
Approved
Apr 2014
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
2

Clinical Trials (2)

NCT01324336N/ACompleted

Comparative Pharmacokinetics of a Compounded 6-mercaptopurine Liquid Formulation Preparation and Tablets

Started Jul 2011
40 enrolled
Acute Lymphoblastic Leukemia
NCT00774982Phase 1Completed

Pilot Comparative Bioavailability Study of 6Mercaptopurine (Delayed Release vs. Purinethol) in Crohns Disease Patients

Started Dec 2008
12 enrolled
Crohns Disease